1. Home
  2. CLMT vs TMDX Comparison

CLMT vs TMDX Comparison

Compare CLMT & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calumet Specialty Products Partners L.P.

CLMT

Calumet Specialty Products Partners L.P.

HOLD

Current Price

$32.69

Market Cap

2.1B

Sector

Energy

ML Signal

HOLD

TMDX

TransMedics Group Inc.

HOLD

Current Price

$75.82

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLMT
TMDX
Founded
1916
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.5B
IPO Year
2024
2019

Fundamental Metrics

Financial Performance
Metric
CLMT
TMDX
Price
$32.69
$75.82
Analyst Decision
Strong Buy
Buy
Analyst Count
5
9
Target Price
$28.65
$148.22
AVG Volume (30 Days)
756.6K
1.2M
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
85.39
382.18
EPS
N/A
0.20
Revenue
$4,137,100,000.00
$605,494,000.00
Revenue This Year
$3.94
$24.25
Revenue Next Year
$1.07
$18.75
P/E Ratio
N/A
$377.40
Revenue Growth
N/A
37.13
52 Week Low
$12.94
$60.11
52 Week High
$38.75
$156.00

Technical Indicators

Market Signals
Indicator
CLMT
TMDX
Relative Strength Index (RSI) 41.87 50.73
Support Level $30.29 $64.90
Resistance Level $33.27 $120.60
Average True Range (ATR) 1.39 3.86
MACD -0.37 1.99
Stochastic Oscillator 10.74 88.70

Price Performance

Historical Comparison
CLMT
TMDX

About CLMT Calumet Specialty Products Partners L.P.

Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: